If you're familiar with traditional motorcycling, you probably know that mastering the clutch is quite rewarding, just like it is in any manual car. Still, newer riders might find the exercise a bit ...

June 15 (Reuters) - Tensordyne said on Monday it expects more than $200 million in orders for its new inference system, as the AI chip startup positions ‌itself as a direct challenger to Nvidia ...

Abu Dhabi National Oil Co. has told its customers to resume loading its crude oil from ports within the Persian Gulf, the company said in a notice sent to customers seen by Bloomberg and corroborated ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Northern Tool + Equipment—a retailer, manufacturer and distributor with more than 120 locations across 20 states—is once more ...

After starting my career at PCMag as an intern more than a decade ago, I’m back as one of its editors, focused on managing laptops, desktops, and components coverage. With 15 years of experience, I ...

Dyne Therapeutics (DYN) said it expanded its senior secured debt facility with Hercules Capital (HTGC) to up to $400M, adding $125M in new borrowing capacity. The amended non-dilutive financing ...

New, higher prices take some of the shine off the MacBook Neo, but Apple's other MacBooks are costlier now, too. Let's look at which of Apple's least-expensive MacBooks makes more sense for what you ...

Starting at $599 ($499 for students), the MacBook Neo comes in a single configuration with just one upgrade option. The brain of the Neo’s operation is the A18 Pro chip. It's a six-core central ...

June 15 (Reuters) - Tensordyne said on Monday it expects more than $200 million in orders for its new inference system, as the AI chip startup positions itself as a direct challenger to Nvidia in a ...

Dyne Therapeutics, Inc. is a clinical-stage company, which engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of ...